American Society of Anesthesiologists

AANA Honors our Nation's Veterans, Supports Better Care And Greater Access to Healthcare in VA

Retrieved on: 
Thursday, November 9, 2023
Anesthesia, Veterans Health Administration, DNP, FAAN, Pain management, Veterans' affairs, Patient, Multimedia, American Medical Association, American Society of Anesthesiologists, Anesthesiology, Autonomy, Trauma, Doctor of Philosophy, Medicare, Veterans Day, ASA, Congress, Society, Legislation, Nursing, Hospital, Veteran

CRNAs deliver high-quality anesthesia care to all populations, including the complex needs of our nation's veterans, due to their specialized and detailed anesthesia training.

Key Points: 
  • CRNAs deliver high-quality anesthesia care to all populations, including the complex needs of our nation's veterans, due to their specialized and detailed anesthesia training.
  • AANA urged the Veterans Affairs (VA) healthcare system to provide the same anesthesia care and services to our veterans as is in place in healthcare systems in 49 states.
  • AANA also refuted the false narrative of physician anesthesiologists that the VA is planning to replace all physician anesthesiologists with CRNAs.
  • Visit this link for more information and to contact your Congressional representative to oppose legislation harming veterans' access to care.

Pacira BioSciences Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 2, 2023
Research, Sale, Anesthesiology, PDUFA, Tax, PIN, Chronic pain, Bupivacaine, 340B Drug Pricing Program, SG, Telephone, Conference, GAAP, Doctor of Philosophy, Health, R, Society, Bank statement, Growth, Interest, ASA, Nerve block, Webcast, Health care, Depreciation, Conference call, Investment, American Society of Anesthesiologists, Table, Bank, Online shopping, Management, Video game, Reinsurance, Pharmaceutical industry, EBITDA, MD

TAMPA, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the third quarter of 2023.

Key Points: 
  • ET --
    TAMPA, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the third quarter of 2023.
  • Total revenues were $163.9 million in the third quarter of 2023, versus $167.5 million reported for the third quarter of 2022.
  • Third quarter 2023 iovera° net product sales were $5.3 million, versus $4.5 million reported for the third quarter of 2022.
  • The Pacira management team will host a conference call to discuss the company’s financial results and recent developments today, Thursday, November 2, 2023, at 8:30 a.m.

Philips Visual Patient Avatar pioneers at-a-glance patient data for faster, better decision-making in the operating room

Retrieved on: 
Friday, October 13, 2023
PHG, Partnership, American Society of Anesthesiologists, DRS, Perception, NYSE, Operating, Certified Registered Nurse Anesthetist, Structural load, BMC Medical Informatics and Decision Making, Philips, PST, MD, British Journal of Anaesthesia, Society, Safety, Hospital, patients, health, territories, ORS, Vital signs, Teaching hospital, Decision, Aircraft, Life, OR, Patient, AEX, Atmosphere, Hospital, Medical imaging, Nursing, Medical device, Anesthesiology

Visual Patient Avatar is designed to improve situational awareness with ground-breaking elegance by visualizing vital information through animations, colors and shapes.

Key Points: 
  • Visual Patient Avatar is designed to improve situational awareness with ground-breaking elegance by visualizing vital information through animations, colors and shapes.
  • By glancing at a monitor with Visual Patient Avatar, anesthesiologists and nurse anesthetists can recall and process critical data more quickly, efficiently and confidently – ultimately helping to save lives.
  • Visual Patient Avatar was designed in partnership with two clinicians at the Visualization Technology Research Group at the Institute of Anesthesiology, University Hospital of Zürich.
  • The inspiration for Visual Patient Avatar came from a hobby of the two clinicians, flying airplanes.

American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.

Retrieved on: 
Thursday, October 12, 2023
American Society of Anesthesiologists, Organization, Anesthesiology, Society, Health, FASA, Education, Anesthesia, Chronic pain, ASA, Patient, Nursing, FAAP

“We are delighted to establish this collaboration with Pacira, which we believe represents an excellent opportunity to advance education and innovation for our members,” said ASA President Michael Champeau, M.D., FAAP, FASA.

Key Points: 
  • “We are delighted to establish this collaboration with Pacira, which we believe represents an excellent opportunity to advance education and innovation for our members,” said ASA President Michael Champeau, M.D., FAAP, FASA.
  • Through the program, Pacira is supporting ASA’s major events, including this year’s ANESTHESIOLOGY® annual meeting, with valuable educational resources to improve patient care.
  • “Pacira is pleased to support ASA and we look forward to collaborating in our efforts to improve patient outcomes through opioid-minimizing strategies,” said Dave Stack, CEO and Chairman of Pacira.
  • We believe that working together, Pacira and the ASA can effect significant change in the best interest of patients.”
    Launched in 2010, ASA’s Industry Supporter Program is limited to 10 organizations at any time.

GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance

Retrieved on: 
Friday, October 6, 2023
Cardiology, Software, Radiology, Health, Artificial Intelligence, Medical Devices, Health Technology, Technology, Diagnosis, Triage, American Society of Anesthesiologists, Acquisition, ACEP, American College, AI, Heart failure, Society, Death, Heart, Emergency, Artificial intelligence, Ultrasound, GE, Caption, ASA, GE HealthCare, Fellow of the American College of Emergency Physicians, Chief digital officer, Digital Solutions, Patient, Anesthesiology, Medical imaging

GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images.
  • The Venue Family is the first among GE HealthCare ultrasound products to incorporate this scan guidance technology following the company’s acquisition of Caption Health earlier this year.
  • “Venue Family ultrasound systems support clinical decision-making at the point of care, including the emergency department, offering simple, fast and precise solutions.
  • GE HealthCare will debut the Venue Family ultrasound systems featuring Caption Guidance, and the Verisound brand, at the American College of Emergency Physicians (ACEP) Scientific Assembly taking place October 9-12 in Philadelphia.

Octapharma USA Presents Factor Concentrates for Perioperative Bleeding Symposium for ASA Annual Meeting Attendees

Retrieved on: 
Tuesday, October 10, 2023
Annual general meeting, Thrombophilia, Algorithm, American Society of Anesthesiologists, Disease, Food, VKA, Bleeding, PST, MD, Society, Mortality, Factor, Hospital, FDA, Food and Drug Administration, Warfarin, Toronto General Hospital, PCC, FC, Octapharma, Duke University, Hemostasis, The Reconstruction (1970 film), ASA, Moscone Center, Toronto, Patient, Nightclub, Dentistry, Pharmaceutical industry, Fibrinogen, Research

PARAMUS, N.J., Oct. 10, 2023 /PRNewswire/ -- Octapharma USA will sponsor the scientific symposium, Factor Concentrates for Perioperative Bleeding – Global Perspectives, Sunday, October 15th in conjunction with the American Society of Anesthesiologists (ASA) Annual Meeting in San Francisco.

Key Points: 
  • PARAMUS, N.J., Oct. 10, 2023 /PRNewswire/ -- Octapharma USA will sponsor the scientific symposium, Factor Concentrates for Perioperative Bleeding – Global Perspectives, Sunday, October 15th in conjunction with the American Society of Anesthesiologists (ASA) Annual Meeting in San Francisco.
  • The symposium will address current gaps in research related to factor concentrates, including prothrombin complex concentrates (PCC) and fibrinogen concentrates (FC), for perioperative bleeding management.
  • Kamrouz Ghadimi, MD, MHSc, Department of Anesthesiology, Duke University, will discuss, "Perioperative Coagulopathic Bleeding – Definition, Treatment Algorithms, and POC Testing, Oh My!"
  • The role of factor concentrates and blood products for management of bleeding in surgery;
    The latest research and current practice guidelines for factor concentrates in perioperative bleeding; and
    Individualized bleeding management strategies in cardiac surgery, with patient case presentations.

Eagle Pharmaceuticals Awarded First Prize for Poster to Be Presented at the International Society for Anaesthetic Pharmacology 32nd Annual Meeting

Retrieved on: 
Wednesday, October 4, 2023
Interim, University, Senior, ISAP, Food, Eagle, Research, American Society of Anesthesiologists, Doctor of Philosophy, MD, Patient, Annual general meeting, Poster, Pharmacology, Regulation of tobacco by the U.S. Food and Drug Administration, Society, International Society, Pharmaceutical industry

WOODCLIFF LAKE, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that its poster, to be presented at the International Society for Anaesthetic Pharmacology (“ISAP”) 32nd Annual Meeting, has been awarded first prize. The presentation, entitled “Pharmacokinetics and pharmacodynamics of remimazolam for procedural sedation in children and adolescents,” summarizes the results of the modeling of the remimazolam pharmacokinetic data by the University of Groningen Medical Center (“UMCG”). The annual ISAP meeting is being held on October 13, 2023, the first day of the American Society of Anesthesiologists (“ASA”) Annual Meeting, in San Francisco, CA.

Key Points: 
  • -- Prize money to be donated to the University of Groningen Medical Center (“UMCG”) research fund, which supports the work of PhD students --
    WOODCLIFF LAKE, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that its poster, to be presented at the International Society for Anaesthetic Pharmacology (“ISAP”) 32nd Annual Meeting, has been awarded first prize.
  • The presentation, entitled “Pharmacokinetics and pharmacodynamics of remimazolam for procedural sedation in children and adolescents,” summarizes the results of the modeling of the remimazolam pharmacokinetic data by the University of Groningen Medical Center (“UMCG”).
  • The annual ISAP meeting is being held on October 13, 2023, the first day of the American Society of Anesthesiologists (“ASA”) Annual Meeting, in San Francisco, CA.
  • “It is an honor to receive first-prize recognition for this important analysis,” stated Valentin Curt, MD, Senior Vice President, Clinical Drug Development and Interim Chief Medical Officer at Eagle Pharmaceuticals.

American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care

Retrieved on: 
Monday, October 2, 2023
Pain management, ASA, Health, American Society of Anesthesiologists, Patient, Society, FASA, Anesthesiology, Nursing, FAAP

SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5 million, by Pacira to the ASA Charitable Foundation, to advance the medical specialty of anesthesiology and pain medicine; facilitate best-in-class clinician education; and improve patient care.

Key Points: 
  • SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5 million, by Pacira to the ASA Charitable Foundation, to advance the medical specialty of anesthesiology and pain medicine; facilitate best-in-class clinician education; and improve patient care.
  • “We look forward to the meaningful progress we can continue to make for our 56,000 members and the patients they serve, supported by this generous grant from Pacira.
  • “Anesthesiologists are an essential ally in our mission to provide long-lasting opioid-free pain relief to as many patients as possible,” said Dave Stack, Chairman and Chief Executive Officer of Pacira.
  • “We are committed to working together, so that ASA and Pacira can effectively advance our common goal of optimizing patient outcomes.

Trevena Announces Receipt of $15 Million Non-Dilutive Tranche and Provides General Business Update

Retrieved on: 
Wednesday, September 6, 2023
Real-World Evidence, Seizure, ASA, Abstract (summary), Abstract, Cleveland Clinic, Central nervous system, Doctor of Pharmacy, Trevena Inc, Use, Senior, Delirium, Vomiting, TMS, Trevena, American Society of Anesthesiologists, Spasm, Research, CNS, Sale, Conference call, Patient, Webcast, Pain, Society, Conference, Receptor, Rare-earth element, Cryptocurrency, Pharmaceutical industry

This tranche of funding was triggered by the first commercial sale of OLINVYK in China by Jiangsu Nhwa, the Company’s licensee in China.

Key Points: 
  • This tranche of funding was triggered by the first commercial sale of OLINVYK in China by Jiangsu Nhwa, the Company’s licensee in China.
  • The $15 million tranche is in addition to the $28.1 million of cash and cash equivalents the Company previously reported as of June 30, 2023.
  • As part of the R-Bridge Financing, Trevena may receive an additional $10 million upon achievement of either a commercial or financing milestone.
  • Trevena expects to report new respiratory data from the study using continuous respiratory monitoring in 3Q 2023.

The Inner Circle Acknowledges, Ruth S. Spector as a Pinnacle Life Member for his contributions to the fields of Internal Medicine, Anesthesia, and Critical Care Medicine

Retrieved on: 
Thursday, August 31, 2023
St. Vincent's Hospital, Critical care, Society, Education, MICU, Society of Critical Care Medicine, Health care, Gift of Life Marrow Registry, Good Samaritan Hospital, Business, Saint Vincent, MBA, Wharton School of the University of Pennsylvania, Private practice, Multimedia, American Society of Anesthesiologists, Mount Sinai Beth Israel, American Thoracic Society, Inner circle, GREAT, Tribe, Federal Executive Boards, Medical director, Patient, Data General Business Basic, Internal medicine, Knowledge, Hospital, Adelphi University, Fellow, George Washington University, Critical Care Medicine (journal), Injury, Nursing, Anesthesia, MD

GREAT NECK, N.Y., Aug. 31, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ruth S. Spector, MD, FCCM, MBA, is acknowledged as a Pinnacle Life Member for his contributions to the fields of Internal Medicine, Anesthesia, and Critical Care Medicine.

Key Points: 
  • GREAT NECK, N.Y., Aug. 31, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ruth S. Spector, MD, FCCM, MBA, is acknowledged as a Pinnacle Life Member for his contributions to the fields of Internal Medicine, Anesthesia, and Critical Care Medicine.
  • Dr. Spector pursued higher education earning a Bachelor of Science degree in General Business at Wharton School of Business.
  • She then obtained a medical degree from George Washington University and completed an Internal Medicine residency at Beth Israel Medical Center in NYC.
  • Board-certified in Internal Medicine, Anesthesia and Critical Care Medicine, Dr. Spector has more than 35 years of experience in the field.